Ascenta Capital
Startup rounds since 2014 with a Ascenta Capital investor on the board, and the firm's own fund filings.
Raises
15
since 2014
Unannounced
2
no announcement found, of those filed since 2025
Funds
2
fund filings under the firm's name
Rounds
- Iambic Therapeutics, Inc.$66M
- Iambic Therapeutics, Inc.$27.8M
- Triana Biomedicines, Inc.$120M
- Iambic Therapeutics, Inc.$99.3M
- OrsoBio, Inc.$40M
- Odyssey Therapeutics, Inc.$117M
- Cardurion Pharmaceuticals, Inc.$260M
- Iambic Therapeutics, Inc.$38.4M
- Abata Therapeutics, Inc.$15.3M
- Iambic Therapeutics, Inc.$103M
- ADARx Pharmaceuticals, Inc.$200M
- ADARx Pharmaceuticals, Inc.$46M
- Abata Therapeutics, Inc.$45M
- Seres Health, Inc.$65M
- Seres Health, Inc.$48M
By year
| Year | Raises | Unannounced |
|---|---|---|
| 2026 | 2 | 2 |
| 2025 | 2 | 0 |
| 2024 | 4 | — |
| 2023 | 4 | — |
| 2022 | 1 | — |
| 2015 | 1 | — |
| 2014 | 1 | — |
Raises are checked for an announcement from 2025 on.
Funds
The firm's own fund filings, each at its latest filing.
| Fund | Filed | Size | Raised |
|---|---|---|---|
| Ascenta Capital Fund I, L.P. | 7 Feb 2025 | $350M | $228M |
| Ascenta Capital SPV I, L.P. | 24 Jan 2023 | $15M | $15M |
Listed because a Ascenta Capital fund's filing names a director of each company. A name match is not a verified identity.